Form 4: Director Bridget Karlin Receives RSU Grant at Lumexa

Director Bridget E. Karlin was granted 19,358 restricted stock units in Lumexa Imaging Holdings, Inc. on June 10, 2026.

Summary

• Director Bridget E. Karlin acquired 19,358 restricted stock units (RSUs) of Lumexa Imaging Holdings, Inc. common stock.
• The transaction occurred on June 10, 2026, at a price of $0 per share, representing a standard equity compensation grant.
• The RSUs are subject to a vesting schedule tied to the earlier of the one-year anniversary of the grant date or the next annual stockholders' meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting is contingent upon the director's continued service with the company.

Future Outlook

The RSUs will vest on the earlier of the one-year anniversary of the grant date (June 10, 2027) or the next annual meeting of the Issuer's stockholders, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to non-executive directors are standard corporate governance practice to ensure long-term alignment between board members and company performance.

Comparison to Industry Standards

• The grant of RSUs to directors is consistent with standard compensation practices for publicly traded companies in the healthcare and imaging technology sectors.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders; reflects standard director compensation.

Next Steps

• Vesting of the 19,358 RSUs on the earlier of June 10, 2027, or the next annual stockholders' meeting.

Key Dates

Keywords

Lumexa Imaging Holdings, LMRI, Form 4, Director Compensation, Restricted Stock Units, Insider Transaction